ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0364

Sex Differences in Clinical and Imaging Characteristics of Axial Juvenile Spondyloarthritis

Adam Mayer1, Timothy G. Brandon2, Pamela F. Weiss3 and on behalf of the JAXSPERT members2, 1University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: ACR Convergence 2023

Keywords: Juvenile Inflammatory Arthritis, Pediatric rheumatology, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The extent to which heterogeneity exists in youth with axial disease and juvenile spondyloarthritis (JSpA) is unclear. In a cross-sectional sample of patients classified as axial disease in JSpA (axJSpA) according to recently validated criteria, we tested for differences in clinical and imaging features amongst males and females.

Methods: This was an international cross-sectional study of youth that met the following criteria: 1) Physician diagnosis of JSpA, 2) Symptom onset prior to age 18 years, 3) Fulfilled criteria for axJSpA. Clinical and magnetic resonance imaging (MRI) data were available from the time when axial disease was first identified; these features were compared between males and females using Pearson’s chi-squared and Fisher’s exact tests for categorical variables, and Wilcoxon rank-sum tests for continuous variables as appropriate. Multivariate logistic regression was used to assess the association of unequivocal inflammatory and structural lesions typical of axial disease on MRI and sex adjusted for HLA-B27 status and degree of inflammatory marker elevation.

Results: 143 patients met inclusion criteria of which 96 (67.1%) were male, 64.0% were HLA-B27 positive, and 18.1% had a family history of spondyloarthritis in a first degree relative. Clinical and imaging characteristics stratified by sex are displayed in Table 1. Male patients had significantly greater prevalence of HLA-B27 positivity (p< 0.01), hip/groin stiffness (p=0.01), inflammatory markers ≥2x the upper limit of normal (p=0.04), pelvic enthesitis (p< 0.01), subchondral bone marrow edema (p< 0.01), and unequivocal sacroiliac joint inflammation on MRI (p< 0.01). There were no statistically significant differences between males and females in peripheral disease manifestations (current or history of) or patient-reported measures. After adjusting for HLA-B27 status and degree of inflammatory marker elevation, the odds of unequivocal inflammatory lesions typical of axial disease (OR 5.70, 95% CI 1.51-21.59), pelvic enthesitis outside the sacroiliac joint (OR 5.92, 95% CI 1.48-23.61) and subchondral bone marrow edema (OR 4.92, 95% CI 1.38-18.12) remained significantly higher in males (Figure 1A) but there were no differences between sexes with respect to structural MRI lesions (Figure 1B). The median axial disease classification score (range 0-100, classification threshold ≥55) was not significantly higher in males.

Conclusion: In patients with JSpA who met validated criteria for axJSpA the prevalence of HLA-B27 positivity, and serologic and imaging evidence of inflammation were significantly higher in males than females. Further exploration of the mechanisms underlying these differences is warranted, but our findings suggest that stratification by sex should be considered in the design of future studies in axJSpA.

Supporting image 1

Table 1. Clinical and imaging features of axJSpA by sex

Supporting image 2

Figure 1. Association of unequivocal (A) inflammatory and (B) structural sacroiliac MRI lesions typical of axial disease and sex, adjusted for HLA-B27 status and degree of inflammatory marker elevation.


Disclosures: A. Mayer: None; T. Brandon: None; P. Weiss: Eli Lilly, 2, Novartis, 2, Pfizer, 2; o. JAXSPERT members: None.

To cite this abstract in AMA style:

Mayer A, Brandon T, Weiss P, JAXSPERT members o. Sex Differences in Clinical and Imaging Characteristics of Axial Juvenile Spondyloarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/sex-differences-in-clinical-and-imaging-characteristics-of-axial-juvenile-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-clinical-and-imaging-characteristics-of-axial-juvenile-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology